Investment Rating - The report does not provide a specific investment rating for the company [3]. Core Insights - The company reported a revenue of 200.41 million yuan for the first nine months of 2024, a year-on-year decrease of 18.97%, with a net profit attributable to the parent company of 20.74 million yuan, down 35.48% year-on-year [1]. - In Q3 2024, the company achieved a revenue of 83.04 million yuan, reflecting a slight increase of 1.71% year-on-year, and a net profit of 12.02 million yuan, which is an increase of 18.74% year-on-year [3][4]. - The gross margin for the first nine months of 2024 was 39.10%, up 2.79 percentage points year-on-year, while the net margin was 10.19%, down 2.69 percentage points year-on-year [1]. - The company has a diversified sales network covering both domestic and international markets, focusing on the development of smart rehabilitation devices and the application of rehabilitation technology in healthy living [2]. Financial Performance Summary - For the first nine months of 2024, the company reported a gross margin of 39.10% and a net margin of 10.19% [1]. - The sales expense ratio was 19.63%, an increase of 2.44 percentage points year-on-year, while the management expense ratio was 4.99%, up 1.38 percentage points year-on-year [1]. - The company’s total assets were reported at 715.65 million yuan, with a net asset value of 525.10 million yuan [2].
倍益康：Q3单季度收入微增，毛利率净利率均提升